ADC Therapeutics (ADCT) Current Taxes (2019 - 2021)

ADC Therapeutics has disclosed Current Taxes across 3 years of filings, most recently posting $3.8 million for Q4 2021.

• Current Taxes for Q4 2021 came in at $3.8 million, up 2419.46% year-over-year; the trailing twelve-month figure through Dec 2021 was $3.8 million (up 2419.46% YoY), and the FY2021 annual result was $3.8 million, up 2419.46% from the prior year.
• Current Taxes came in at $3.8 million for Q4 2021 at ADC Therapeutics, up from $149000.0 in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $3.8 million in Q4 2021 to a low of $52000.0 in Q4 2019.
• The 3-year median for Current Taxes is $149000.0 (2020), against an average of $1.3 million.
• Across the five-year window, Current Taxes surged 186.54% in 2020 and surged 2419.46% in 2021, its largest moves.
• ADC Therapeutics' Current Taxes stood at $52000.0 in 2019, then soared by 186.54% to $149000.0 in 2020, then soared by 2419.46% to $3.8 million in 2021.
• The last three Current Taxes figures came in at $3.8 million (Q4 2021), $149000.0 (Q4 2020), and $52000.0 (Q4 2019), per Business Quant data.